MONICA BOMAR: Open Payments
NPI 1578819405 · BALD KNOB, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 30 payments from 7 companies in 2025. Trend: 2023 $517 · 2024 $364 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $401 |
| Lundbeck LLC | 2 | $50 |
| Viatris Specialty LLC | 2 | $48 |
| Lilly USA, LLC | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Novo Nordisk Inc | 1 | $18 |
| Insulet Corporation | 1 | $18 |
Products named: VRAYLAR, REXULTI, YUPELRI, BREZTRI, ZEPBOUND, Ozempic, Omnipod, MOUNJARO.
Industry payments across AR — which companies pay providers there.
